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Background: In Chile, the clinical guidelines “for the treatment of people from first episode
of schizophrenia” aim to support individuals with schizophrenia to live independently, estab-
lishment occupational goals, and gain an adequate quality of life and social interaction.This
requires the implementation of a treatment model that integrates psychosocial and phar-
macological dimensions. Community intervention strategies ensure the achievement of
these goals.
Objectives:This study compiles and synthesizes available scientific evidence from the last
14 years on the effectiveness of community intervention strategies for schizophrenia and
related psychotic disorders.
Methodology:An electronic search was carried out using PUBMED, LILACS, and Science
Direct as databases.
Criteria of inclusion: (i) randomized clinical trials, (ii) Community-based interventions, (iii)
diagnosis of schizophrenia or related psychotic disorder (section F2 of ICD-10). Exclusion
Criteria: (i) treatments exclusively pharmacological, (ii) interventions carried out in inpatient
settings, (iii) bipolar affective disorder or substance-induced psychosis (greater than 50%
of sample).
Results: Sixty-six articles were reviewed. Community strategies for integrated treatment
from the first outbreak of schizophrenia significantly reduced negative and psychotic symp-
toms, days of hospitalization, and comorbidity with substance abuse and improved global
functioning and adherence to treatment. In other stages, there were improved outcomes
in negative and positive symptoms and general psychopathology. Psychoeducation for
patients and families reduced the levels of self-stigma and domestic abuse, as well as
improved knowledge of the disease and treatment adherence. Training focused on cog-
nitive, social, and labor skills has been shown to improve yields in social functioning and
employment status.
Conclusion: Community-based intervention strategies are widely supported in the treat-
ment of patients with schizophrenia.
Keywords: schizophrenia, psychotic disorders, community health services, community mental health centers,
psychosocial interventions
INTRODUCTION
In Chile, there have been great advances in national mental health
policies, which have culminated in the establishment of guaran-
teed treatment for four mental disorders: schizophrenia, starting
with the first episode; depression in individuals over 15; abuse and
dependence on alcohol and drugs in individuals younger than 20;
and bipolar disorder in individuals 15 years of age or older (1).
The clinical guidelines “for the treatment of people beginning
in the first episode of schizophrenia,” published in 2009, aim to
support patients with schizophrenia so that they may live inde-
pendently, establish and pursue occupational goals, increase social
interaction, and achieve a reasonable quality of life. It is essential to
have a comprehensive treatment plan, which includes psychoso-
cial and pharmacological dimensions and assures the continua-
tion of these two dimensions throughout the treatment process.
It is therefore recommended that the psychosocial interventions
include adherence support, art therapy, cognitive-behavioral ther-
apy (CBT), cognitive rehabilitation, counseling and therapeutic
support, family interventions, psychodynamic and psychoanalytic
therapy, psychoeducation, and social skills training, and that, in
line with the new community model for mental health, these
interventions be carried out within the community (2).
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The objective of this study is to review the existing scientific evi-
dence on the effectiveness of psychosocial community treatments
for schizophrenia and related psychotic disorders (F2 spectra of
the ICD-10, F20 schizophrenia, F22 delusional disorder, F23 brief
psychotic disorders, F25 schizoaffective disorder, F29 unspecified,
non-organic psychosis).
METHODOLOGY
A qualitative review of literature from 1999 to 2012 was performed.
Even though we did not carry out a systematic review, we used
PICOS criteria (P, participants; I, interventions; C, comparisons;
O, outcomes; S, study design) from the PRISMA guidelines, for
selection of the studies (3).
Our investigative question was: what is the effectiveness of non-
pharmacological community treatments for the management of
schizophrenia and related psychotic disorders?
The studies were selected according to the following inclusion
criteria:
– Participant population: patients with schizophrenia and disor-
ders with psychotic features (delusional disorder, schizoaffective
disorder, brief psychotic disorder, schizophreniform disorder,
unspecified non-organic disorder).
– Type of intervention: community mental health services.
– Study design: prospective randomized controlled clinical trials
(CCT).
– Outcomes: clinical (symptoms), user satisfaction, adherence to
treatment, unmet needs, social functioning, occupational func-
tioning, cognitive functioning, use of services, quality of life,
hospitalizations, costs.
– Publication period: 1999–2012.
– Language: English/Spanish
The studies went through a second screening in accordance
with exclusion criteria, which ensured that the reviewed articles
complied with the conditions established in the investigative ques-
tion. For this reason, studies that included the following were
excluded:
– Participant population: bipolar affective disorder (greater than
50% of the sample), substance-induced psychosis (greater than
50% of the sample)
– Type of intervention: exclusively pharmacological or inpa-
tient treatment. Studies that described the design of protocols,
without preliminary results.
PubMed was the principal search database, and LILACS and
Science Direct were used as alternatives. For PubMed, the MeSH
key words used were: “schizophrenia and disorders with psychotic
features” and “community mental health services.” The search was
filtered for year of publication (01 January 1999 until 31 Decem-
ber 2012), type of article (Clinical Trial, Randomized Controlled
Trial), and language (English, Spanish).
There were 113 article hits in the PubMed search, 33 in LIL-
CAS, and 216 in Science Direct. After the abstracts were reviewed,
according to the exclusion-inclusion criteria, and screened for
duplicate hits, there were 66 articles remaining (59 from PubMed,
6 from LILACS, and 1 from Science Direct). The entire text of each
of the 66 articles was reviewed.
The process of data extraction was carried out by three quali-
fied readers, who used a spreadsheet with corresponding instruc-
tions to compile information according to the following variables:
author, participants, age, intervention, total number of patients,
follow-up, outcomes, randomization, blinding, intention-to-treat
analysis, analysis of groups at baseline (and if they are comparable),
results (with the corresponding statistical data).
RESULTS
Of the 66 reviewed articles, 17 were randomized clinical trials
of interventions for patients with first-episode psychosis, and
the remaining 49 evaluated interventions designed for patients
in other stages of the illness. All of the studies included phar-
macological interventions as part of the treatment, alongside the
psychosocial community interventions, which were considered the
independent variable.
CHARACTERISTICS OF THE STUDIES
Sixty-five of the articles were CCT and only one corresponded to
an observational study, which was included given its relevance to
the objectives of the review. Of the 65 CCTs, 63 were randomized,
and 43 described some type of blinding. The 65 CCTs carried out
a comparison of the baseline characteristics of the study groups,
and in 55 of the articles, the groups were completely similar at
baseline; only 10 articles presented significant differences in some
of the studied variables at baseline. Intention-to-treat analysis was
used in only 32 studies. The loss of patients during follow-up
varied between 5.3 and 53%. The total number of subjects that
participated in the selected CCTs ranged from 24 to 708 patients.
Systematic reviews were not included, since the objective of
this review was to gather information coming solely from original
studies.
INTERVENTIONS FOR FIRST-EPISODE PSYCHOSIS
Seventeen of the reviewed articles evaluated interventions for
first-episode psychosis (Table S1 in Supplementary Material).
A series of five articles covered the OPUS trial in Denmark, a
large randomized clinical trial of a 2-year program of modified
assertive community treatment (ACT), multi-family group psy-
choeducation, and social skills training. In comparison to standard
treatment (ST), the intervention significantly reduced psychotic
symptomatology [Scale for the Assessment of Positive Symptoms
(SAPS)], and negative symptomatology [Scale for the Assessment
of Negative Symptoms (SANS)], and improved global function-
ing (GAF). In addition, OPUS reduced the number of hospitalized
days by 22%, and adherence to comprehensive treatment was 8%
greater, with more user satisfaction (4). However, the effects on
symptomatology were not sustained at the 5-year follow-up (5).
Additionally, OPUS reduced substance use in a population with
dual-pathology (6), and in the subgroup of high risk of psychosis
(schizotypal disorder), the percentage of transitioned to psychosis
at 2 years was only 25% (vs. 48.3% in the ST group). Multivari-
able analysis showed a reduced risk for transition into psychosis
(RR: 0.36) (7). There were no significant differences in quality of
life (8).
Frontiers in Psychiatry | Schizophrenia October 2013 | Volume 4 | Article 116 | 2
Armijo et al. Community treatments for schizophrenia
OPUS intensive treatment (IT) was compared with hospital
based rehabilitation (HBR) and ST, and both HBR and IT showed
improvements in negative symptomatology at 1-year follow-up.
Additionally, all three groups showed high levels of user satis-
faction in terms of quality of life. The IT group presented fewer
days/bed (IT:−139.1, ST:−53.6; HBR: reference), a greater num-
ber of patients living independently (IT: 68.8% vs. HBR: 40.0%
vs. ST: 37.0%), and higher quality of life scores. There were no
significant differences in the use of coercive measures (9).
“The Lambeth Early Onset Team” (London, England) tested
a biopsychosocial intervention consisting of ACT along with
evidence-based interventions according to the needs of each
patient (CBT, family counseling, vocational strategies), carried
out by a multi-professional community mental health team, for
people presenting to mental health services for the first or second
time with non-organic, non-affective psychosis. After adjusting for
sex, number of previous psychotic episodes, and ethnicity, results
showed a reduction in the average number of readmissions vs. ST
(specialized care 0.4 vs. controls 0.8) and the lower dropout rate
(OR: 0.28) (10). The intervention group had more reduced nega-
tive symptoms (PANSS) and increased GAF, although the PANSS
results were not maintained after adjusting for race, sex, or num-
ber of episodes. The outcomes were also better in satisfaction
(Verona Service Satisfaction Scale), quality of life (MANSA), and
pharmacological adherence. In addition, the patients maintained
educational or work activities for a longer period of time than the
control group (6.9 vs. 4.2 months) (11). Patients receiving special-
ized care reported a greater average number of significant others
in their social network (2.40± 1.20 vs. 1.71± 1.06), which lin-
ear regression analysis correlated with significant improvement in
total PANNS and GAF (β= 2.95, SE= 1.04), showing the impor-
tance of social network in clinical improvement (12). Nevertheless,
the intervention did not maintain results after 5-years follow-
up in the re-hospitalization rates or in the average number of
days/bed (13). There were also no significant differences in cost
when compared to ST (14).
The early detection education program for general practitioner
associated with the Lambeth Early Onset Crisis Assessment Team
(LEOCAT) significantly increased the number of general doctors
that referred patients directly to mental health services (86.1 vs.
65.7%), as well as reduced the delay before treatment initiation
(5.9% of the patients evaluated by trained doctors delayed start-
ing treatment more than 3 months vs. 27.3% of patients evaluated
by untrained doctors, p< 0.05). However, the average duration of
untreated psychosis (DUP) was not changed, as the intervention
impacted only the final phases of the DUP (15).
Another group in London, the “Croydon Outreach and
Assertive Support Team” (COAST), carried out an intervention
consisting of treatment with atypical antipsychotics, cognitive-
behavioral psychotherapy, a family intervention, and social and
vocational assistance, delivered by a multi-professional team that
was available 24 h a day, 7 days a week. Upon comparison with
usual treatment (TAU: caseload= 35, without psychotherapy,
including only medication monitoring and access to services),
it was found that both groups improved the PANSS outcomes
of positive symptomatology and general psychopathology, and in
the regression analyses, the treatment-time interaction was not
significant for any of the measures. It is not clear why COAST
could not demonstrate significant improvements over TAU. One
possibility is that patients were referred to the service and many
of them were relatively stable, suggesting that the specialist input
provided was not always necessary for this particular sample (16).
The Early Psychosis Prevention and Intervention Centre
(EPPIC), in Melbourne,Australia, was created to provide thorough
community treatment for patients, age 15–29, with first-episode
psychosis. One of the interventions was cognitively oriented psy-
chotherapy for early psychosis (COPE), consisting of weekly 40-
min sessions, which progress through four phases (engagement,
assessment, adaptation, secondary morbidity). After the 4-year
follow-up, there was improvement in all the evaluated clinical
variables (positive, negative, general, and depressive symptoms;
quality of life; social functioning; reduction in readmissions) but
without significant differences with respect to the control group
(17). In the same context, a vocational intervention of individ-
ual placement and support (IPS) was evaluated. It consists of a
vocational support method that offers protected work accord-
ing to seven key principles: focus on competitive employment;
treatment open to anyone with a mental illness; work search begin-
ning at entry into program; program integrated into the mental
health treatment team; job search based on patients’ preferences;
time-unlimited support, continuing after employment is obtained,
adapted to needs of patient; and counseling regarding the use of
social benefits. The intervention group presented a greater num-
ber of employed patients (IPS= 13 vs. TAU= 2), number of hours
worked per week (median IPS= 38 vs. TAU= 2.5),number of total
jobs received (IPS= 23 vs. TAU= 3), and total earnings (mean
IPS=U$4,449 vs. TAU=U$3,615). Additionally, the intervention
group worked for a longer duration (median IPS= 5 weeks vs.
TAU= 0) and showed a reduction by 55% in the number of peo-
ple who required social welfare payments as their main source of
income (18).
Early Psychosis Prevention and Intervention Centre also imple-
mented cannabis and psychosis therapy (CAP), a cognitive-
behavior program to reduce harm resulting from the consumption
of marijuana. The intervention was carried out in 10 weekly ses-
sions, 20–60 min each, over the course of 3 months. The program
resulted in a reduction of cannabis use, with a median of 4 days of
use in the 4 weeks leading up to the start of the study vs. 2 days at
the end of treatment, and 1 day in the 4 weeks before the 6-month
follow-up. These results, however, were also observed in the group
that only received psychoeducation (19).
The Graduated Recovery Intervention Program (GRIP) is a
thorough yet flexible module-based program with CBT, psychoe-
ducation, and social skills training that aims to improve illness
management and facilitate functional recovery after a first psy-
chotic episode. The intervention program consists of 36 indi-
vidual sessions with four modules: commitment and well-being
management, substance use, persistent symptoms, and functional
recovery. Although the majority of mixed model analyses were not
statistically significant, examination of within-group changes and
effect sizes suggests an advantage for GRIP over TAU in improv-
ing functional outcomes. GRIP participants showed improve-
ment in social functioning (Role Functioning Scale=−2.96) and
social competence (Multnomah Community Ability Scale-Social
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Competence subscale=−3.23) and tended to have a reduced
PANSS general psychopathology subscale. Additionally, the TAU
group had twice as many hospitalizations as the GRIP group
(GRIP= 4 vs. TAU= 9) (20).
INTERVENTIONS FOR OTHER STAGE OF ILLNESS
The remaining 49 reviewed articles evaluated interventions for
patients in others stages of schizophrenia (Table S2 in Supplemen-
tary Material).
Assertive community treatment
A total of nine randomized clinical studies evaluated the efficacy
of ACT in patients with more advanced states of psychosis. The
principal outcomes used in five of the studies were heterogeneous
(severity of symptoms, GAF, hospital admissions, continual con-
tact with community network, housing stability, self-management,
user satisfaction) with an evaluation time ranging from 1 to 3 years.
Of the remaining studies, two evaluated interventions specifically
targeted to a forensic subpopulation, one evaluated a group with
dual-pathology, and the final evaluated cost-effectiveness of an
intervention.
Three studies evaluated symptom severity (PANNS, BPRS,
CGI-S), finding significant improvements in favor of the interven-
tion group (21–23), which also showed significant improvements
in GAF (SOFAS) (21, 23), user satisfaction (CSQ) (21, 22), qual-
ity of life (Q-LES), and occupation (23). However, the results
were mixed in terms of number of admissions and number of
days of hospitalization. The study of Botha et al. (21) showing
fewer readmissions and fewer days hospitalized, while the study
of Bhugra et al. (22) did not detect significant differences. How-
ever, this was probably due to the fact that the Bhugra et al.
intervention was directed at a culturally vulnerable subpopula-
tion (black population), 10% of which was made up of bipolar
patients.
The two remaining studies showed an increase in the number of
monthly contacts between the patients and ACT team and a greater
number of monthly home visits (24), as well as an improvement
in substance abuse (SATS scale) and a great percentage of patients
living independently (25).
In a similar vein, the intervention directed toward patients with
psychosis and dual-pathology showed a lower probability of poor
adherence over time (26).
The application of ACT for a forensic population – “Mental
Health Treatment Court” (MHTC) – did not show significant
differences in the reduction of criminal behavior but did show
significant improvements in quality of life (Lehman QOL Life
Satisfaction Scale), psychological distress (BASIS-32), and drug
consumption (27). At the 2-year follow-up, F-ACT (forensic ACT)
showed a reduced number of imprisonments, an increased num-
ber of contacts within the community health system, and fewer
days hospitalized. Though it was more expensive to treat patients
in the community, the costs associated with imprisonment were
reduced per patient (28).
Finally, the evaluation of cost-effectiveness in the REACT
study, which defined effectiveness as user satisfaction in rela-
tion to cost, showed a greater cost per worker in ACT, greater
cost of hospital care in ACT, and greater monthly costs in ACT.
The cost-effectiveness ratio was U$747 for each extra unit of
satisfaction offered by ACT, with greater user satisfaction in
ACT (29).
Intensive case management
Intensive case management (ICM) interventions optimize ACT,
through the inclusion of client-focused case management,
manual-based interventions, and comprehensive post-discharge
treatment. We reviewed 10 studies that evaluated ICM inter-
ventions: 6 evaluated clinical outcomes, 2 evaluated the average
number of days hospitalized, 1 evaluated a forensic population,
and 1 evaluated cost-effectiveness.
The six interventions which evaluated clinical outcomes were
found to increase user satisfaction, lessen caregiver burden (30,
31), improve psychiatric symptoms (CPS-50, BPRS) (32), reduce
unmet needs (CAN) (32, 33), improve GAF (MFIS), reduce dis-
ability (DI, WHODAS) (31, 32), decrease caregiver stress (GCS)
(32), and improve quality of life (Quality of Life Scale, QoL) (32),
without significant differences in suicidal conduct (suicide attempt
or completed suicide) (34) or violent behavior (35).
With respect to hospitalized days, the UK700 study found that
a reduced caseload had no impact on the average number of days
hospitalized over the 2-year period (36), and one study which
evaluated impact of ICM upon “heavy users” of acute psychiatric
inpatient beds (the 10% of patients that were most frequently hos-
pitalized in a determined time period) found a fourfold increase
in community contacts. However, there were no significant differ-
ences in any of the other clinical outcomes (37). The inclusion of
more severe patient groups in these studies could explain the lack
of significant difference, given that in the UK700 study, exclud-
ing a subpopulation of forensic patients reduced the number of
hospitalized days significantly (ICM= 30 days vs. TAU= 60 days,
p= 0.02) (36).
In a forensics population, intensified services for court-ordered
outpatient care did not show significant differences in the studied
variables (arrests, quality of life, and symptomatology) in either
group, and the percentage with re-hospitalizations was similar.
These results, however, were influenced by the study limitation
that no control measures were put in-place to assure the adherence
of typically non-adherent patients, who generally ended up being
re-hospitalized (38); a similar study found that patients who were
more adherent to the outpatient care program had fewer readmis-
sions (57% fewer readmissions), fewer days hospitalized (20 fewer
days on average), and less probability of violent behavior (27 vs.
42%) or being victimized (24 vs. 42%) (39).
An evaluation of the costs associated with ICM in Hong Kong,
China found that there were significantly greater average costs
for the intervention group, when compared to the control group
(40). Harrison et al. also showed that total costs were greater in
the experimental group, due to increased spending on outpatient
community and primary care services, and a greater number of
visits to general practitioners in the experimental group (37).
Community re-entry module
Three articles evaluated the Community re-entry module (CRM),
which consists of nurse-led psychoeducation sessions cover-
ing self-administration of medications, early signs of relapse,
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emergency relapse plans, how to find housing, continuing care in
the community, stress reduction, and promotion of coping strate-
gies upon discharge. In one study, CRM vs. standard rehabilitation
showed improvements in knowledge and skills in medication and
symptom management, as well as a significant improvement in
the REHAB scale at 1-year follow-up, but there were no significant
differences in symptomatology (41). In another study, CRM vs.
standard group psychoeducation reported significant differences
at the 2-year follow-up in symptomatology (PANSS), reemploy-
ment rate, insight, and social functioning. Additionally, there were
lower rates of re-hospitalization and relapses (42). CRM vs. sup-
portive counseling found improvements in all subscales of PANSS
and social functioning in favor of the intervention group (43). The
differences in symptomatology improvement are probably due to
the fact that in one study, CRM was compared with an inpatient
integrated rehabilitation program, which included arts and crafts,
reality orientation therapy groups, and work assignments, while
the other two studies compared CRM to interventions that were
limited to one aspect of illness management. An advantage of
CRM is that it is community-based, and all three studies showed
improvements in social functioning.
Cognitive-behavioral therapy
Six studies evaluated the efficacy of CBT in patients with schiz-
ophrenia. The outcomes were mainly clinical: psychotic symp-
toms (PANSS), depression (Beck and Calgary Depression Scale
for Schizophrenia), and anxiety (Social Interaction Anxiety Scale,
Brief Social Phobia Scale, Brief Fear of Negative Evaluation Scale),
relapses, psychosocial functioning, insight, and quality of life were
also evaluated. Follow-up period varied between 1 and 3 years.
Significant differences were found in positive symptomatology
(44, 45), negative symptomatology (45–47), and depressive symp-
toms and suicide (45, 47); however, the reduction of depression
symptoms was the only result that was still significant at the 18-
month follow-up (45). CBT also showed better outcomes in global
and social functioning (44, 45), a reduced number of hospitaliza-
tions (44, 46, 47), and improvement in insight about the disease
and symptoms (45–47). Furthermore one study evaluated group
CBT and found that it significantly improved anxiety, depres-
sion, symptomatology, and quality of life (48). There were no
significant differences in the intervention costs or occupational
recovery (45, 46).
Another study which evaluated a needs-based family cognitive-
behavior intervention for caregivers showed a lower relapse rate
(37 vs. 72%, NNT= 3), significant improvements in PANSS
for both groups (p= 0.005), and better GAF in the interven-
tion group, though without differences in the caregiver vari-
ables (49).
Cognitive rehabilitation and social cognition
Five studies evaluated the effects of interventions focused on cog-
nitive rehabilitation and improving social cognition. The first
study was non-randomized and investigated the influence of
both factors in psychosocial rehabilitation programs. The rate
of rehabilitative change was statistically significant at follow-up
and high neurocognition and social cognition scores at baseline
predicted higher rates of rehabilitative change. Similarly, more
days of treatment were associated with higher rates of functional
change (50).
The four remaining studies were randomized, with a 3- to
12-month follow-up, and evaluated three interventions: Social
Cognitive Enhancement Training (SECT), Feuerstein’s Dynamic
Cognitive intervention, and Cognitive Adaptation Training (CAT).
SCET vs. standard rehabilitation showed better results in the Social
Behavior Sequencing Task, which measures ability to use social
sequential information, and in the Picture Arrangement Task
(p< 0.05), which measures perceptual and sequential organiza-
tional ability (distinguishing what is essential from peripheral in
social context) (51). Feuerstein’s Dynamic Cognitive Intervention
showed significant differences in memory and thought processes
[Learning Potential Assessment Device (LPAD) and the Raven Pro-
gressive Matrices and General Aptitude Test Battery (GATB)] and
gains in employment (31 vs. 14%) and independent living (44.4 vs.
17%) (52). CAT includes interventions carried out for 14 days, over
the course of 6 months, in the patients’ homes according to patient
profile: apathy, disinhibition, and dysexecutive syndrome, mea-
sured by the Frontal System Behavior Scale and Wisconsin Card
Sorting Test. CAT vs. ACT alone showed significant improvements
in the secondary outcomes for both groups, in terms of needs
(CAN), symptomatology (PANSS), and quality of life (Lehman
Quality of Life Interview), but there were no significant differences
between the groups in any outcome, including GAF (primary out-
come) (53). A study comparing CAT vs. Global Environmental
Support – GES (generic support, without individualized differ-
ences) and CAT vs. TAU showed that CAT and GES had higher
average social and occupational functioning (SOFAS) with sig-
nificant differences in comparison to ST, but without significant
differences between the two intervention groups (54).
Psychoeducation regarding Illness
Five studies evaluated psychoeducational interventions: three
investigated patient and family joint pscyhoeducation sessions,
and two evaluated patient-only psychoeducation. The patient and
family psychoeducation interventions had a follow-up between 9
and 24 months.
A training program designed for Latino patients and their
families showed significant differences when compared to the
control group, at the 9-month follow-up, in terms of sympto-
matology, symptom management, medication management, func-
tioning level, and rates of re-hospitalization (5.1 vs. 22.2%) (55).
There were, however, no significant differences in quality of life
or caregiver burden between the intervention and control groups.
In another study, multi-family group psychoeducation produced
a lower rate of psychiatric hospitalization in comparison to ST,
although the results were not statistically significant (56). Fam-
ily psychoeducation program in six rural towns in China yielded
greater adherence to treatment, less family neglect and abuse, and
greater understanding of the mental illness (57).
The patient-only psychoeducation interventions – the
Evidence-Based Practices Implementation Project in Japan (58)
and a psychoeducation program for Korean Americans (59) –
showed improvements in the intervention groups symptomatol-
ogy (BPRS) (58, 59), GAF, quality of life (SF-36), quality of social
relationships (LSS), and self-sufficiency in daily living activities
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(SECL) (58). The intervention groups also showed lower Stigma-
Devaluation Scale scores and greater scores on the Family Crisis
Oriented Personal Evaluation Scales (59).
Family therapy
We found only one study that evaluated the effectiveness of a year-
long systemic family therapy for schizophrenia. At the first year of
follow-up, the users in the family therapy group had lower rates
of relapse than the usual treatment group (15 vs. 65%, p= 0.03),
fewer consultations with the psychiatric emergency department (5
vs. 40%, p= 0.02), and were more adherent to medication (100 vs.
65%, p= 0.009). These differences, however, were not maintained
at the second year of follow-up (60).
Crisis intervention plans
Two studies evaluated the effectiveness of Crisis Intervention
Plans.
Critical Time Intervention (CTI) is a time-limited intervention
that aims to assure the continuity of users’ care, during the transi-
tion from institutional settings to the community. Technical “CTI
Workers” are paired with patients before discharge and help the
patients strengthen ties with formal and informal supports in the
community. CTI was shown to significantly reduce the number
of “homeless” nights in a prior publication by Susser et al. (71).
CTI also improves negative symptoms (PANSS negative symptom
subscale), compared to usual treatment (CTI=−2.6 vs. USO+ 1,
p= 0.02). However, when only the results of patients with a diag-
nosis of schizophrenia were analyzed, there were no significant
differences (CTI=−2.9 vs. USO=+5, p= 0.70) (61).
Flood et al. evaluated the cost-effectiveness of joint crisis plans,
which are formulated by the patient, caregiver, psychiatrist, and
project worker. The results showed that the use of joint cri-
sis plans is associated with fewer forced hospitalizations (13 vs.
27%, RR= 0.48) and fewer total hospitalizations (30 vs. 44%;
RR= 0.69), though the latter was not statistically significant.
The total cost of the 15-month follow-up was £7,264 (C10,616,
U$13,560) for each participant in the experimental group, vs.
£8,359 (C12,217, U$15,609) in the control group. The cost-
effective analysis reveals that there is a 78% probability that these
crisis planning programs are more cost-effective than the stan-
dard presentation of information, due to their role in reducing the
probability of hospital admissions (62).
Computer-mediated community interventions
Four of the reviewed studies investigated the effectiveness of
computer-mediated community interventions. One study eval-
uated an online support platform, and the others evaluated the
DIALOG program, a computer-mediated intervention with struc-
tured communication between health workers and patients that
also measures the patients’ satisfaction.
Griswold et al. assessed the use of an online support platform in
an ACT program to connect patients to primary care services after
a crisis episode. The support platform was staffed by caregivers,
who were trained in interviewing, case evaluations, and manag-
ing patients in psychiatric emergencies, and provide information
about care centers, facilitate access to primary care, perform psy-
choeducation, give information about diagnoses and treatment,
follow-up (including a home visit), and connect patients with
peers via community mental health and social services web sites. At
the 1-year follow-up, the intervention group was more connected
to support services than the control group (62.4 vs. 37.6%) (63).
The multi-center DIALOG study found that, a year after
the computer-mediated intervention, patients with predomi-
nately negative symptoms had a greatly improved quality of life
(MANSA), and that this result was primarily moderated by the
quality of the therapeutic alliance at the beginning of treat-
ment and by the duration of the illness. Additionally, patients
who were most symptomatic at the beginning of treatment were
found to have a reduced number of unmet needs (CANSAS),
which was moderated by the presence of competitive employ-
ment and shorter illness duration (64). The study also reported
improvements in the quality of life scales (65, 66) and user
satisfaction (66).
Therapy to encourage adherence
Three studies evaluated the effectiveness of Therapy to Encourage
Adherence. One study of adherence therapy did not find signif-
icant differences when compared with the control group, which
only received health education in terms of quality of life, adher-
ence, or psychopathology (67). A training program for community
nurses in the medication management for schizophrenia patients
vs. usual management training reduced patient symptomatology
(PANSS) (68). A pharmacy-based intervention, which used a plan
to help patients remember their prescriptions and medication
schedule through calendar-based containers, was found to signifi-
cantly increase the medication possession ratio (MPR) – the ratio
between the number of days medicine was given to the patient and
the number of days he or she should have received medication (69).
DISCUSSION
The literature review identified articles on a wide range of com-
munity psychosocial treatments for schizophrenia. While the stud-
ies were of diverse methodological quality, the majority com-
plied with the standards of randomization, blinding, and initial
group analysis, even though only half of the studies performed
intention-to-treat analysis.
The main methodological limitation identified is the diversity
of interventions and control groups used in each of the studies.
In many investigations, the ST already involved community-based
interventions, and the intervention group optimized various fac-
tors of the preexisting interventions. In the case of interventions
for first-episode psychosis (OPUS, LEO, COAST, EPPIC, CAP, and
GRIP), the “standard care” received by the control group was often
also delivered by community mental health teams and had the
following characteristics: increased caseload size of 20 to 35, no
additional training in the management of early psychosis, and
no specialized psychological, social, or psychoeducational inter-
ventions (such as COPE, IPS, CAP, and GRIP). For interventions
targeting other stages of the disease, control groups were more
heterogeneous, but shared some common general characteristics.
In ACT and ICM, ST was also implemented by community mental
health teams but differs from intervention groups in the follow-
ing: greater caseloads, not home based, did not include assertive
engagement or after-hours services, and finally, the frequency
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of contact with patients varied between every month to every
3 months, and depended on caseloads, rather than on patients’
needs. The control groups for CBT, CRM, cognitive rehabilitation,
psychoeducation, family therapy, computer-mediated community
interventions, and crisis intervention plans lacked for the specific
intervention.
A second methodological limitation was the heterogeneity of
sample sizes. On interventions for first-episode schizophrenia,
major studies (OPUS, N = 547; LEO, N = 466) have sufficient
number of patients to test the power of their results, but studies
with smaller sample sizes (COAST, N = 59; COPE, N = 91; IPS,
N = 41; CAP, N = 47; GRIP, N = 46) require additional inves-
tigations to support their results. In the case of interventions
for other disease states, sample size variability is even greater.
For ICM and ACT, while the studies of Botha et al. (N = 60),
Bhugra et al. (N = 83), and Chan et al. (N = 62) had fewer than
100 subjects, most other studies – i.e., Lambert et al. (N = 120),
Salyers et al. (N = 324), Walsh et al. (N = 708), etc. – had a
larger sample size, giving to their results more weight. In terms
of other types of interventions, the sample sizes of Malik et al.
(N = 257) and Turkington et al. (N = 422) for CBT, Velligan
et al. (N = 120) for CAT, and Dyck et al. (N = 106), and Mao Ran
et al. (N = 357) for psychoeducation were noteworthy. The sample
sizes for computed-mediated community interventions (Griswold
et al. N = 151; DIALOG, N = 507), crisis plans interventions (Her-
man et al. N = 99; Flood et al. N = 160), and therapy to encourage
adherence (Gray et al. N = 409;Valenstein et al. N = 118) were also
quite significant.
Another limitation to consider in our study is the possibil-
ity of the existence of publication bias: the tendency to submit
articles based on the direction or magnitude of the results, thus
over-representing certain characteristics of the studies. The main
potential risk factors for publication bias are (1) the characteris-
tics of study design (sample size, type of control group, number
of collaborating centers), (2) the characteristics of the researcher,
(3) the financing source, and (4) strength of the results.
Firstly, to reduce study design bias, we attempted to perform
a varied and exhaustive search to ensure the inclusion of studies
with smaller samples, given the potential tendency to publish stud-
ies with larger sample sizes because its larger effect size. We also
did not reject studies based on the characteristics of the control
group and included both: multicentric and local studies. In terms
of study design, the selected articles were only randomized clini-
cal trials. The large variability of sample sizes and control groups,
and the presence of local and multi-center studies, evidences the
rigor with which we followed the search criteria to avoid publica-
tion bias. Second, we included young and senior researchers, from
both the hospital and the community setting. Third, in terms of
financing, the study did not receive direct funding; instead, it was
financially supported by a regional mental health research network
known as Rede Americas, which aims to support the careers and
training of young investigators in Latin Americas. Finally, regard-
ing to strength of the results, we have tried to include both results
with statistical significance as well as those with non-significant or
negative results, in order to avoid publication bias.
Unfortunately, it is not possible to calculate “fail-safe N ” in
our study, since that requires meta-analysis. We suggest in future
researches carry out a meta-analysis of community treatments for
schizophrenia, in order to quantify the results of our review.
Taking into account the aforementioned methodological limi-
tations, it is important to assess of the applicability of the reviewed
interventions in Chile. Our clinical guidelines recommend psy-
chosocial community interventions for the recovery phase of
schizophrenia, but the implementation of such interventions
requires specialized human resources (such as case managers and
cognitive-behavioral therapists). Our challenge, is training pri-
mary care professional and technical staff, to carry out the different
interventions. Moreover, the inclusion of “peers”– individuals who
also suffer from a severe mental illness – as rehabilitation monitors,
also appears to be a alternative to improve human resources, intro-
duce users into the community mental health service network, and
encourage recovery (70).
Finally, it must be noted that most of interventions were carried
out in the recovery and/or social insertion phase of schizophrenia
treatment, but also in the acute phase, that did not exclude hos-
pitalization as a therapeutic alternative. Interventions analyzed in
this review and hospitalized care should not be viewed as mutually
exclusive. Community-based treatment should be viewed as a way
to enhance treatment of schizophrenia, primarily in the phases
of recovery and social integration. We maintain that the analyzed
studies are innovative and provide good quality scientific evidence.
CONCLUSION
Community psychosocial interventions for schizophrenia have
been found to be effective in reducing positive and negative
symptomatology and general psychopathology, both after the first
psychotic episode and in other phases of the illness. The effects
on negative symptoms are of particular interest, since these com-
munity interventions can serve as a complementary alternative
to manage refractory symptoms, which at times are unresponsive
even to treatment with atypical antipsychotics.
Additionally, evidence shows that community-based psychoso-
cial interventions significantly reduce relapses and hospital read-
missions, increase contacts with the community mental health
teams, and improve adherence to pharmacological treatment.
They do not, however, reduce costs.
The majority of the evaluated interventions reported improve-
ments in GAF, social functioning, and user satisfaction. Voca-
tional interventions result in successful job reintegration, and psy-
choeducation interventions have been shown to increase under-
standing of the illness and crisis management. The results also
indicate that incorporating a culturally accepted program for
a subpopulation of family members of a patient with severe
mental illness yields better results than usual treatment. Fur-
thermore, devising crisis plans in conjunction with the patients
themselves is an effective strategy to prevent and manage sit-
uations that often lead to decompensation, and in the case
of acute episodes, to address them in a timely manner, thus
improving symptomatic results and reducing the number of
hospitalizations.
Cognitive-behavioral therapy yields excellent results in terms
of improving negative and positive symptomatology, general psy-
chopathology, and depressive and anxiety symptoms, and it has
been found to reduce the rates of relapse and re-hospitalization.
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Group versions of CBT have similarly been shown to reduce
anxiety and social anxiety, and systemic family therapy also has
produced positive results.
Family interventions are also effective in improving patient
adherence and in reducing relapses and the use of emergency
services, highlighting the necessity of including family members,
whenever possible, in all comprehensive treatment programs for
schizophrenia.
Cognitive rehabilitation and social cognition-focused inter-
ventions, which have been found to restore memory processes
and executive functions and to improve symptomatology and
psychosocial outcomes, should be more widely investigated and
implemented.
Further, the implementation of computer technologies to con-
nect with patients with schizophrenia has reported good results,
leading to increased contact with caregivers and improved quality
of life and user satisfaction.
The reviewed community-based interventions, which integrate
evidence-based treatment strategies, offer a comprehensive treat-
ment approach for schizophrenia and have reported high levels
of social and clinical recovery, thus making possible the thera-
peutic outcomes desired by individuals with schizophrenia and
their families: the ability to live independently, establish and pur-
sue occupational goals, establish social relationships, and improve
quality of life.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at http://www.frontiersin.org/Schizophrenia/10.3389/fpsyt.2013.
00116/abstract
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